A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Clinical trial NCT00996762 · COMPLETED

Trial details

NCT number: NCT00996762
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2009-11-12
Primary completion: 2012-09-18
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.